13/11/2023 Other Services
If you are not located in the United States, products that appear to be misbranded or unapproved new drugs are subject to detention and refusal of admission if they are offered for importation into the United States.
The U.S. FDA may advise the appropriate regulatory officials in the country from which you operate that FDA considers your product(s) referenced above to be unapproved and misbranded products that cannot be legally sold to consumers in the United States.
TB HOLDINGS LLC
390 North Orange Avenue, Suite 2300
Orlando, FL 32801
United States
T: +1 855 389 7344
T: +1 855 510 2240
T: +44 800 610 1577
https://www.itbhdg.com/drugs/
Animal Drugs and Feeds regulatory activities account for 4 percent of FDA’s budget. However, 22 percent of these activities are paid for by industry u...
FDA issues Warning Letters to companies illegally selling cannabidiol (CBD) and delta-8 tetrahydrocannabinol (Delta-8 THC) products. Violations includ...
Our clients around the world are mostly startups, small and medium-sized enterprises (SMEs). Import-Export Companies Contract Manufacturers Medical De...
If you are not located in the United States, products that appear to be misbranded or unapproved new drugs are subject to detention and refusal of adm...
More Details